12,265
edits
If you're interested in becoming a contributor or requesting changes then click here to join the discord
Changes
Jump to navigation
Jump to search
no edit summary
Line 5:
Line 5:
ExAblater 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment ofsymptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.+
[[Category:Organizations]]
[[Category:Organizations]]
[[Category:Companies]]
[[Category:Companies]]
−"InSightec develops and manufactures MR-guided Focused Ultrasound technology devices for image-guided acoustic surgery."